U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710586) titled 'Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China: A Phase IV Study' on July 14.

Brief Summary: This study evaluates the safety of the quadrivalent subunit influenza vaccine in individuals aged 3 years and older in Jiangsu Province, China. The primary objectives are to assess the occurrence of very rare adverse reactions (incidence <0.01%), investigate the incidence of cerebral infarction following vaccination, and evaluate the incidence of systemic adverse events among participants aged 9 to 17 years.

Study Start Date: Nov. 15, 2024

Study Type: INTERVENTIONAL

Condition: Influenza Vaccine

Interv...